Xue Lin

3PUBLICATIONS
9CO-AUTHORS
Molecular medicineLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 04, 2025
FDA Approval Summary: Idecabtagene Vicleucel for the Treatment of Triple-Class-Exposed, Relapsed or Refractory Multiple Myeloma.

Poornima Sharma, Xue Lin, Zhenzhen Xu

|Jul 05, 2023
FDA Approval Summary: Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma.

Poornima Sharma, Yvette L Kasamon, Xue Lin

|May 25, 2022
Summary of US Food and Drug Administration Chimeric Antigen Receptor (CAR) T-Cell Biologics License Application Approvals From a Statistical Perspective.

Xue Lin, Shiowjen Lee, Poornima Sharma

Pageof 1

Frequent Collaborators

2 joint publications

Poornima Sharma

2 joint publications

Zhenzhen Xu

2 joint publications

Marc R Theoret

1 joint publications

John Scott